Combiwave 25/125 mcg Inhalation

Read the user manual carefully before use. If you need more information, consult your doctor. This drug is for a doctor's prescription. What is Combowave SF 125? The drug is used by inhalation, used for both adults and children. Uses – Indications of Combiwave SF 125 Combiwave SF 125 is indicated for the maintenance treatment of airway obstruction and exacerbation in patients with COPD and to reduce all-cause mortality. Routine treatment of reversible airway obstruction including asthma in adults and children over 4 years of age. (includes patients inadequately controlled with inhaled corticosteroids and short-acting beta2-agonists as needed or who remain symptomatic while on inhaled corticosteroid therapy or who are effectively controlled with maintenance doses of corticosteroids) sprays and long-acting beta 2 agonists). Combiwave SF 125 . Composition Each inhalation dose contains: Salmeterol Xinafoate 5,808mg Fluticasone Propionate 20mg Excipients are sufficient. How to use and dosage Combiwave SF 125 How to use: Use by inhalation through the mouth. Use regularly for good results. Asthma: Adults & Adolescents ≥ 12 years: 2 sprays (25mcg salmeterol/50mcg fluticasone propionate), 2 times/day Or 2 sprays (25mcg salmeterol/125mcg fluticasone propionate), 2 times/day. Or 2 sprays (25mcg salmeterol/250mcg fluticasone propionate), twice daily. Up to 500/50, 2 times/day. Children over 4 years: 2 sprays (25mcg salmeterol/50mcg fluticasone propionate), twice daily. Up to 100 mcg Fluticasone, 2 times/day. COPD disease: Adults: 2 sprays 25/125 microgram to 25/250 microgram salmeterol/fluticasone propionate, twice daily. Doses of 50/500 micrograms twice daily reduced all-cause mortality. Elderly or liver/kidney impairment: No dose adjustment is required. Combiwave SF 125 contraindications To avoid unwanted side effects, the following people should not use: Do not use for people who are hypersensitive to any ingredient of the drug. Combiwave SF 125 side effects The side effects when using the drug such as: tremor, feeling of palpitations, headache. Arrhythmia. Oropharyngeal irritation. Cramp. Hoarseness/hoarseness, thrush & throat. Cushing's disease, Cushing's sign, adrenal suppression, growth retardation in children & adolescents, decreased bone mineral density, cataracts, glaucoma. Pneumonia. Be careful while using Combiwave SF 125 Use caution when administering the drug to patients with pulmonary tuberculosis, thyrotoxicosis, pre-existing cardiovascular disease, prone to hypokalemia, a history of diabetes, and children under 4 years of age. Use Combiwave SF 125 for pregnant and lactating women Do not use the drug for pregnant and lactating women. Interactions with other drugs and other types of interactions Avoid concomitant use: Ritonavir, beta-blockers. Combination cautions: Strong inhibitors of CYP3A4. Store at a temperature below 25°C, away from moisture and direct sunlight. How to use Compuwave It is recommended to move the inhaler for five minutes before use. The patient should rinse the mouth with water after each use.